Back
Harrow Health 10K Form
Buy
77
HROW
Harrow Health
Last Price:
21.29
Seasonality Move:
22.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HROW News And Ratings
See the #1 stock for the next 7 days that we like better than HROW
HROW Financial Statistics
Sales & Book Value
| Annual Sales: | $88.6M |
|---|---|
| Cash Flow: | $-9.75M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.92 |
| Price / Book: | 22.58 |
Profitability
| EPS (TTM): | -0.52000 |
|---|---|
| Net Income (TTM): | $-14.09M |
| Gross Margin: | $63.21M |
| Return on Equity: | -125.91% |
| Return on Assets: | -12.8% |
Harrow Health Earnings Forecast
Key Harrow Health Financial Ratios
- The Gross Profit Margin over the past 16 years for HROW is 71.34%.
- The Selling, General & Administrative Expenses for HROW have been equal to 65.73% of Gross Profit Margin.
- The Research & Development expenses have been 3.44% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of HROW is -15.90% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 9 years.
Harrow Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Current Symbol: | HROW |
| CUSIP: | 415858 |
| Website: | harrowinc.com |
Debt
| Debt-to-Equity Ratio: | 3.78 |
|---|---|
| Current Ratio: | 6.35 |
| Quick Ratio: | 5.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HROW Technical Analysis vs Fundamental Analysis
Buy
77
Harrow Health (HROW)
is a Buy
Is Harrow Health a Buy or a Sell?
-
Harrow Health stock is rated a Buy
The current Harrow Health [HROW] share price is $20.80. The Score for HROW is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.